Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
As a part of the partnership with Alveofit, AstraZeneca has deployed spirometers at selected hospitals across the country. This include ESIC hospitals for industrial employees, Command and Military Hospitals, General Hospitals and last mile clinics in cities like Lucknow, Chennai, Nagpur, Delhi, Ahmedabad and Kolkata, , astrazeneca india, Alveofit, lung diseases